Does OSIMERTINIB Cause Torsade de pointes? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Torsade de pointes have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
30
Reports of Torsade de pointes with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Torsade de pointes From OSIMERTINIB?
Of the 30 reports, 4 (13.3%) resulted in death, 16 (53.3%) required hospitalization, and 18 (60.0%) were considered life-threatening.
Is Torsade de pointes Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Torsade de pointes?
AMIODARONE (522)
LOPERAMIDE (366)
ONDANSETRON (331)
FUROSEMIDE (305)
METHADONE (240)
CITALOPRAM HYDROBROMIDE (182)
QUETIAPINE (172)
OLANZAPINE (171)
HYDROXYCHLOROQUINE (167)
FLUOXETINE (164)
Which OSIMERTINIB Alternatives Have Lower Torsade de pointes Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN